• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

罗马尼亚人群中林奇综合征风险变异的鉴定。

Identification of Lynch syndrome risk variants in the Romanian population.

机构信息

deCODE genetics/AMGEN, Reykjavik, Iceland.

School of Science and Engineering, Reykjavik University, Reykjavik, Iceland.

出版信息

J Cell Mol Med. 2018 Dec;22(12):6068-6076. doi: 10.1111/jcmm.13881. Epub 2018 Oct 16.

DOI:10.1111/jcmm.13881
PMID:30324682
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6237568/
Abstract

Two familial forms of colorectal cancer (CRC), Lynch syndrome (LS) and familial adenomatous polyposis (FAP), are caused by rare mutations in DNA mismatch repair genes (MLH1, MSH2, MSH6, PMS2) and the genes APC and MUTYH, respectively. No information is available on the presence of high-risk CRC mutations in the Romanian population. We performed whole-genome sequencing of 61 Romanian CRC cases with a family history of cancer and/or early onset of disease, focusing the analysis on candidate variants in the LS and FAP genes. The frequencies of all candidate variants were assessed in a cohort of 688 CRC cases and 4567 controls. Immunohistochemical (IHC) staining for MLH1, MSH2, MSH6, and PMS2 was performed on tumour tissue. We identified 11 candidate variants in 11 cases; six variants in MLH1, one in MSH6, one in PMS2, and three in APC. Combining information on the predicted impact of the variants on the proteins, IHC results and previous reports, we found three novel pathogenic variants (MLH1:p.Lys84ThrfsTer4, MLH1:p.Ala586CysfsTer7, PMS2:p.Arg211ThrfsTer38), and two novel variants that are unlikely to be pathogenic. Also, we confirmed three previously published pathogenic LS variants and suggest to reclassify a previously reported variant of uncertain significance to pathogenic (MLH1:c.1559-1G>C).

摘要

两种家族性结直肠癌(CRC)形式,林奇综合征(LS)和家族性腺瘤性息肉病(FAP),分别由 DNA 错配修复基因(MLH1、MSH2、MSH6、PMS2)和 APC 和 MUTYH 基因的罕见突变引起。关于罗马尼亚人群中是否存在高危 CRC 突变,尚无信息。我们对 61 例有癌症家族史和/或疾病早发的罗马尼亚 CRC 病例进行了全基因组测序,重点分析 LS 和 FAP 基因中的候选变异。在 688 例 CRC 病例和 4567 例对照中评估了所有候选变异的频率。对肿瘤组织进行了 MLH1、MSH2、MSH6 和 PMS2 的免疫组织化学(IHC)染色。我们在 11 例中发现了 11 个候选变异;MLH1 中有 6 个变异,MSH6 中有 1 个,PMS2 中有 1 个,APC 中有 3 个。结合对变异对蛋白质的预测影响、IHC 结果和以往报告的信息,我们发现了三个新的致病性变异(MLH1:p.Lys84ThrfsTer4、MLH1:p.Ala586CysfsTer7、PMS2:p.Arg211ThrfsTer38)和两个不太可能是致病性的新变异。此外,我们还证实了三个先前发表的致病性 LS 变异,并建议将先前报道的意义不明的变异重新归类为致病性(MLH1:c.1559-1G>C)。

相似文献

1
Identification of Lynch syndrome risk variants in the Romanian population.罗马尼亚人群中林奇综合征风险变异的鉴定。
J Cell Mol Med. 2018 Dec;22(12):6068-6076. doi: 10.1111/jcmm.13881. Epub 2018 Oct 16.
2
Associations of Pathogenic Variants in MLH1, MSH2, and MSH6 With Risk of Colorectal Adenomas and Tumors and With Somatic Mutations in Patients With Lynch Syndrome.MLH1、MSH2 和 MSH6 中的致病性变异与林奇综合征患者结直肠腺瘤和肿瘤的风险及体细胞突变的相关性。
Gastroenterology. 2020 Apr;158(5):1326-1333. doi: 10.1053/j.gastro.2019.12.032. Epub 2020 Jan 8.
3
Universal screening for Lynch syndrome in endometrial cancers: frequency of germline mutations and identification of patients with Lynch-like syndrome.林奇综合征在子宫内膜癌中的普遍筛查:种系突变的频率及林奇样综合征患者的鉴定。
Hum Pathol. 2017 Dec;70:121-128. doi: 10.1016/j.humpath.2017.10.022. Epub 2017 Oct 28.
4
Clinical and molecular detection of inherited colorectal cancers in northeast Italy: a first prospective study of incidence of Lynch syndrome and MUTYH-related colorectal cancer in Italy.意大利东北部遗传性结直肠癌的临床与分子检测:意大利林奇综合征和MUTYH相关结直肠癌发病率的首次前瞻性研究
Tumour Biol. 2012 Jun;33(3):857-64. doi: 10.1007/s13277-011-0312-0. Epub 2012 Jan 26.
5
Mismatch repair gene mutation spectrum in the Swedish Lynch syndrome population.瑞典林奇综合征人群中的错配修复基因突变谱。
Oncol Rep. 2016 Nov;36(5):2823-2835. doi: 10.3892/or.2016.5060. Epub 2016 Sep 1.
6
Lessons learnt from implementation of a Lynch syndrome screening program for patients with gynaecological malignancy.从为妇科恶性肿瘤患者实施林奇综合征筛查计划中吸取的经验教训。
Pathology. 2017 Aug;49(5):457-464. doi: 10.1016/j.pathol.2017.05.004. Epub 2017 Jun 30.
7
Germline variants screening of MLH1, MSH2, MSH6 and PMS2 genes in 64 Algerian Lynch syndrome families: The first nationwide study.对 64 个阿尔及利亚林奇综合征家族的 MLH1、MSH2、MSH6 和 PMS2 基因进行种系变异筛查:首次全国性研究。
Ann Hum Genet. 2022 Nov;86(6):328-352. doi: 10.1111/ahg.12482. Epub 2022 Sep 8.
8
Screening for germline mutations of MLH1, MSH2, MSH6 and PMS2 genes in Slovenian colorectal cancer patients: implications for a population specific detection strategy of Lynch syndrome.斯洛文尼亚结直肠癌患者种系 MLH1、MSH2、MSH6 和 PMS2 基因突变的筛查:对林奇综合征人群特异性检测策略的影响。
Fam Cancer. 2009;8(4):421-9. doi: 10.1007/s10689-009-9258-4. Epub 2009 Jun 13.
9
Germline MLH1, MSH2 and MSH6 variants in Brazilian patients with colorectal cancer and clinical features suggestive of Lynch Syndrome.巴西结直肠癌患者中与林奇综合征临床特征相关的种系 MLH1、MSH2 和 MSH6 变异。
Cancer Med. 2018 May;7(5):2078-2088. doi: 10.1002/cam4.1316. Epub 2018 Mar 25.
10
Rare germline mutation and MSH2-&MSH6 + expression in a double primary carcinoma of colorectal carcinoma and endometrial carcinoma: a case report.罕见的种系突变和 MSH2-MSH6 表达在结直肠癌和子宫内膜癌的双原发癌中:一例报告。
Diagn Pathol. 2024 Jan 31;19(1):25. doi: 10.1186/s13000-024-01447-8.

引用本文的文献

1
Deciphering the Therapeutic Applications of Nanomedicine in Ovarian Cancer Therapy: An Overview.纳米医学在卵巢癌治疗中的治疗应用解析:综述。
Curr Drug Deliv. 2024;21(9):1180-1196. doi: 10.2174/0115672018253815230922070558.
2
Clinical diagnosis and endoscopic analysis of 10 cases of intestinal tuberculosis.10例肠结核的临床诊断与内镜分析
Medicine (Baltimore). 2020 Jul 10;99(28):e21175. doi: 10.1097/MD.0000000000021175.
3
Ovarian cancer in the world: epidemiology and risk factors.全球卵巢癌:流行病学与风险因素
Int J Womens Health. 2019 Apr 30;11:287-299. doi: 10.2147/IJWH.S197604. eCollection 2019.

本文引用的文献

1
ClinVar: improving access to variant interpretations and supporting evidence.ClinVar:改善变异解读和支持证据的获取。
Nucleic Acids Res. 2018 Jan 4;46(D1):D1062-D1067. doi: 10.1093/nar/gkx1153.
2
Whole genome characterization of sequence diversity of 15,220 Icelanders.对 15220 名冰岛人进行全基因组序列多样性特征分析。
Sci Data. 2017 Sep 21;4:170115. doi: 10.1038/sdata.2017.115.
3
Comprehensive population-wide analysis of Lynch syndrome in Iceland reveals founder mutations in MSH6 and PMS2.冰岛对林奇综合征的全面人群分析揭示了 MSH6 和 PMS2 中的种系突变。
Nat Commun. 2017 May 3;8:14755. doi: 10.1038/ncomms14755.
4
Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics.临床外显子组和基因组测序中次要发现报告的建议,2016年更新版(美国医学遗传学与基因组学学会次要发现v2.0):美国医学遗传学与基因组学学会政策声明
Genet Med. 2017 Feb;19(2):249-255. doi: 10.1038/gim.2016.190. Epub 2016 Nov 17.
5
Analysis of protein-coding genetic variation in 60,706 humans.对60706名人类的蛋白质编码基因变异进行分析。
Nature. 2016 Aug 18;536(7616):285-91. doi: 10.1038/nature19057.
6
The Ensembl Variant Effect Predictor.Ensembl变异效应预测器。
Genome Biol. 2016 Jun 6;17(1):122. doi: 10.1186/s13059-016-0974-4.
7
High microsatellite instability (MSI-H) colorectal carcinoma: a brief review of predictive biomarkers in the era of personalized medicine.高微卫星不稳定性(MSI-H)结直肠癌:个性化医疗时代预测生物标志物的简要综述
Fam Cancer. 2016 Jul;15(3):405-12. doi: 10.1007/s10689-016-9884-6.
8
Patients with colorectal cancer associated with Lynch syndrome and MLH1 promoter hypermethylation have similar prognoses.患有林奇综合征且伴有MLH1启动子高甲基化的结直肠癌患者具有相似的预后。
Genet Med. 2016 Sep;18(9):863-8. doi: 10.1038/gim.2015.184. Epub 2016 Feb 11.
9
The intolerance to functional genetic variation of protein domains predicts the localization of pathogenic mutations within genes.蛋白质结构域功能遗传变异的不耐受性可预测基因内致病突变的定位。
Genome Biol. 2016 Jan 18;17:9. doi: 10.1186/s13059-016-0869-4.
10
Deficient mismatch repair: Read all about it (Review).错配修复缺陷:全面了解(综述)。
Int J Oncol. 2015 Oct;47(4):1189-202. doi: 10.3892/ijo.2015.3119. Epub 2015 Aug 12.